Message Board

Message Board
Share questions and answers on issues impacting the ASC community in Maryland. (Members Only)
more information

Career Center

Career Center
Check out the various employment opportunities within field of ambulatory surgery care in Maryland.
more information

Resources

Resources
Keep up-to-date on regulations and best practices. Other helpful resources are compiled here for your convenience.
more information

Vendors

Vendors
Visit our online Vendor Directory and support fellow MASA member businesses that serve our ambulatory surgery centers.
more information

Welcome

The health care industry is constantly evolving and many forces are competing to guide and shape this process.  Working together to create opportunities helps all of us achieve our goals.

The mission of the Maryland Ambulatory Surgery Association is to ensure the choice of quality health care at cost effective rates.

There is strength in numbers and power in unity.  Competing interests in the health care industry are threatened by ambulatory surgery centers and the choice they provide to health care consumers.  This powerful opposition is well-equipped and continues to initiate policy adverse to freestanding surgery centers.  MASA can help you fight back.

Latest News & Info

05/15/2018

Hagerstown surgery center completes first total knee replacement without narcotics

Hagerstown Herald-Mail (MD) (05/07/18) Bonk, Valerie

MASA Member, Cumberland Surgery Center, performed the first total joint replacement surgery for the center in which doctors and anesthesiologists would not use narcotics.

Details >
05/07/2018

MEMA Leds Virtual "Atlantic Fury " Exercise

Twenty-five ASCs across Maryland participated in today's "Atlantic Fury" Virtual Emergency Preparedness Private Sector Exercise. This exercise represents MEMA's dedication to engaging with the private sector as we all prepare for, respond to, and recover from emergency events. As in a real disaster, MEMA disseminated notifications, situation updates, and other relevant information from their Business Operations Center. MEMA followed the exercise with a hotwash (immediate "after-action" discussion and evaluation) allowing the ASC representatives to provide feedback.

Details >
04/19/2018

Annual Prescription Take Back Day

April 28, 2018

On Saturday, April 28, from 10 a.m. to 2 p.m. the Drug Enforcement Administration will give the public its 15th opportunity in 7 years to prevent pill abuse and theft by ridding their homes of potentially dangerous expired, unused, and unwanted prescription drugs. The service is free and anonymous, no questions asked. Last fall Americans turned in 456 tons (912,000 pounds) of prescription drugs at more than 5,300 sites operated by the DEA and almost 4,300 of its state and local law enforcement partners. Overall, in its 14 previous Take Back events, DEA and its partners have taken in more than 9 million pounds—more than 4,500 tons—of pills. This initiative addresses a vital public safety and public health issue. Medicines that languish in home cabinets are highly susceptible to diversion, misuse, and abuse. Rates of prescription drug abuse in the U.S. are alarmingly high, as are the number of accidental poisonings and overdoses due to these drugs. The Substance Abuse and Mental Health Services Administration’s National Survey on Drug Use and Health shows year after year that the majority of misused and abused prescription drugs are obtained from family and friends, including someone else’s medication being stolen from the home medicine cabinet. In addition, Americans are now advised that their usual methods for disposing of unused medicines—flushing them down the toilet or throwing them in the trash—both pose potential safety and health hazards.

Details >
03/30/2018

FDA Releases Draft Guidance on Bulk Drug Compounding

Last Friday, the FDA released a new draft guidance regarding bulk drug substances that outsourcing facilities can use for compounding. This is part of the FDA’s larger 2018 Compounding Policy Priorities Plan that was covered back in February. This guidance in particular covers what the FDA considers when determining whether a bulk substance will be safe to compound, and how they will keep track of those substances that have been approved or not. A new “503B Bulks List” managed by the FDA will delineate those substances deemed safe to compound. Nominations to the list will be made on a rolling basis, and the FDA will determine whether there is a “clinical need” for the substance to be compounded based on a multi-step process.

Details >
View All

Calendar

 May 2018 
SMTWTFS
  12345
6789101112
13141516171819
20212223242526
2728293031  
Wed
13
2018
June 13, 2018
6:00-8:30PM

Reprocessing and Infection Control Meeting

Columbia Sheraton Town Center

View All